Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.37 |
| ▸ | TGM2 | P21980 | 2/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL529016 | 0.82 | HSD17B10 (0.43) | HSD17B10TSHR | |
| SCHEMBL24090588 | 0.78 | HSD17B10 (0.41) | HSD17B10SLC6A9TGM2S1PR1TSHR | |
| SCHEMBL1468774 | 0.77 | HSD17B10 (0.56) | HSD17B10SLC6A9TGM2S1PR1 | |
| SCHEMBL9116656 | 0.77 | HSD17B10 (0.56) | HSD17B10SLC6A9TGM2S1PR1 | |
| SCHEMBL9119179 | 0.77 | HSD17B10 (0.56) | HSD17B10SLC6A9TGM2S1PR1 | |
| SCHEMBL9119800 | 0.75 | HSD17B10 (0.54) | HSD17B10SLC6A9TGM2S1PR1 | |
| SCHEMBL9117714 | 0.75 | HSD17B10 (0.54) | HSD17B10SLC6A9TGM2S1PR1 | |
| SCHEMBL9118000 | 0.75 | HSD17B10 (0.54) | HSD17B10SLC6A9TGM2S1PR1 | |
| SCHEMBL25629531 | 0.75 | HSD17B10 (0.34) | HSD17B10 | |
| SCHEMBL173508 | 0.74 | HSD17B10 (0.64) | HSD17B10SLC6A9S1PR1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7605146-B2 | Process for producing an amide compound | NIHON MEDI-PHYSICS COMPANY, LIMITED (JP) | 2009-10-20 | — | — | US | claimed |
| EP-1199312-B1 | Process for producing an amide compound | SUMITOMO CHEMICAL CO (JP) | 2004-07-21 | — | — | EP | claimed |
| US-20020077456-A1 | Process for producing an amide compound | NIHON MEDI-PHYSICS COMPANY, LIMITED (JP) | 2002-06-20 | — | — | US | claimed |
| EP-1199312-A2 | Process for producing an amide compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-04-24 | — | — | EP | claimed |
| US-7605146-B2 | Process for producing an amide compound | NIHON MEDI-PHYSICS COMPANY, LIMITED (JP) | 2009-10-20 | — | — | US | disclosed |
| EP-1199312-B1 | Process for producing an amide compound | SUMITOMO CHEMICAL CO (JP) | 2004-07-21 | — | — | EP | disclosed |
| US-20020077456-A1 | Process for producing an amide compound | NIHON MEDI-PHYSICS COMPANY, LIMITED (JP) | 2002-06-20 | — | — | US | disclosed |
| EP-1199312-A2 | Process for producing an amide compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020077456-A1 | Process for producing an amide compound | NAAA, ACMSD, CPS1 | HSD17B10 1556/4885SLC6A9 2241/4885TGM2 736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.